BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3274832)

  • 1. The impact of cyclosporine A on the DRw6 effect in renal transplantation.
    Hendriks GF; de Lange P; Schreuder GM; D'Amaro J; Persijn GG; van Rood JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):650-1. PubMed ID: 3274832
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of DR and DR6 matching on cadaver kidney transplant survival.
    Reyman TA; Toledo-Pereyra LH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
    [No Abstract]   [Full Text] [Related]  

  • 3. DR6 compatibility and kidney graft survival.
    Correia AM; de Costa AG; Reis P; Rego F; Sampaio MJ; Caetano JM; Pena JR
    Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
    [No Abstract]   [Full Text] [Related]  

  • 4. Is HLA-DRw6 antigen matching necessary in living donor renal transplant?
    Kim SI; Kim YS; Suh JS; Lee EM; Park K
    Transplant Proc; 1992 Aug; 24(4):1312-3. PubMed ID: 1496570
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients.
    Opelz G; Schwarz V; Engelmann A; Back D; Wilk M; Keppel E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):373-5. PubMed ID: 1990556
    [No Abstract]   [Full Text] [Related]  

  • 6. Local use of kidneys with poor HLA matches is as good as shared use with good matches in the cyclosporine era: an analysis at one and two years.
    Alexander JW; Vaughn WK; Pfaff WW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):672-4. PubMed ID: 3274836
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of donor and recipient DRw6 status on outcome of cadaver kidney transplantation.
    Vereerstraeten P; Andrien M; Dupont E; De Pauw L; Kinnaert P; Toussaint C
    Transplant Proc; 1987 Feb; 19(1 Pt 1):708-10. PubMed ID: 3547836
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine A, hyperimmunized patients, and renal retransplantation.
    Hendriks GF; de Lange P; Persijn GG; van Rood JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):733-4. PubMed ID: 3274857
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue typing in renal transplantation: the impact of cyclosporine.
    Benvenisty AI; Cohen DJ; Hardy MA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):19-28. PubMed ID: 2938321
    [No Abstract]   [Full Text] [Related]  

  • 10. The results of renal transplantation with cyclosporine in immunologically high-risk patients.
    Dickerman RM; Vergne-Marini P; Langley J; Trevino G; Velez R; Brinker K; Nesser D; Long D; Hull AR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1846-8. PubMed ID: 3079047
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA-DR1 recipients have the highest kidney transplant survival.
    Cook DJ; Cecka JM; Terasaki PI
    Transplant Proc; 1987 Feb; 19(1 Pt 1):675-7. PubMed ID: 3274837
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching.
    Hoitsma AJ; Van Lier HJ; Reekers P; Koene RA
    Neth J Med; 1985; 28(6):239-42. PubMed ID: 3892324
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effects of peritransplant variables on short- and predicted long-term outcome in cyclosporine-treated recipients of cadaveric renal allografts.
    Lindholm A; Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Persson N; Groth CG
    Transplant Proc; 1990 Aug; 22(4):1429-30. PubMed ID: 2202118
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of HLA-DRw6 on donor-recipient selection in kidney transplantation.
    Hendriks GF; D'Amaro J; Persijn GG; Schreuder GM; Cohen B; Van Rood JJ
    Neth J Med; 1985; 28(6):235-8. PubMed ID: 3892323
    [No Abstract]   [Full Text] [Related]  

  • 16. DNA typing of 3500 cadaver kidney transplants does not confirm the "DR6 effect".
    Mytilineos J; Scherer S; Dunckley H; Trejaut J; Chapman J; Middleton D; Savage D; Fischer G; Fae I; Bignon JD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):207-9. PubMed ID: 8094909
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of immunological risk factors on the outcome of cadaveric renal transplantation as revealed in transplants with primary graft anuria.
    Madsen M; Fjeldborg O; Rasmussen A; Povlsen JV; Kissmeyer-Nielsen F
    Transplant Proc; 1990 Aug; 22(4):1371-2. PubMed ID: 2389332
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of DRw6 antigen in recipients and donors on survival after liver transplant.
    Superina RA; Pearl RH; Greig PD; Levy G; Falk J; Langer B
    Transplant Proc; 1989 Feb; 21(1 Pt 1):786-8. PubMed ID: 2650270
    [No Abstract]   [Full Text] [Related]  

  • 19. A past positive crossmatch does not affect allograft survival for cyclosporine-immunosuppressed primary and secondary renal transplant recipients.
    Quinn T; Louis P; Mallis M; Senitzer DS; Tellis V; Matas A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):704. PubMed ID: 2650232
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of HLA matching, donor age, and cyclosporine on unrelated pediatric renal allograft survival.
    Groenwoud AF; Persijn GG; Hendriks GF; D'Amaro J; Cohen B
    Transplant Proc; 1987 Feb; 19(1 Pt 1):699-701. PubMed ID: 3274847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.